Catheter-associated infections
CAUTIs are among the most common healthcare-associated infections. Biofilm formation on catheter surfaces is one factor associated with catheter-associated infection.
CE-marked medical device
T-Control® is an indwelling urinary catheter with an integrated flow-control valve designed to support controlled urinary drainage and simplify catheter management.
The clinical problem
Indwelling catheterization remains one of the most frequent invasive procedures in hospitals — and one of the most frequent sources of avoidable harm, discomfort and workload.
CAUTIs are among the most common healthcare-associated infections. Biofilm formation on catheter surfaces is one factor associated with catheter-associated infection.
Bypass leakage around the catheter causes discomfort, soiling and additional care episodes.
Catheter care includes recurring tasks such as bag management, hygiene, monitoring and management of complications.
A visible urine drainage bag can affect mobility, discretion and day-to-day activities for some catheter users.
The solution
The integrated valve allows the bladder to fill between drainage episodes when intermittent drainage is clinically appropriate, instead of continuous free drainage.

Value proposition
A control valve integrated in the catheter allows drainage to be opened and closed, with fewer handling steps during catheter management.
Supports controlled bladder filling and emptying rather than continuous free drainage when clinically appropriate.
T-Control® can also be connected to a urine drainage bag for continuous drainage when clinically indicated.
Designed to support aseptic catheterisation technique and to simplify day-to-day catheter management for clinical teams.
Who it is for
Healthcare professionals
Insertion technique, protocol adherence, training resources and the scientific work behind the device.
Patients & carers
What changes with T-Control®, what to expect and where to find instructions and support.
Training
Our official training video walks clinical teams through the correct handling of the device step by step.
External recognition
Recognition of Rethink Medical's innovation, scientific work and entrepreneurial journey.

4× European Commission Seals of Excellence
3 Horizon 2020 · 1 EIC Accelerator
Awarded following competitive European Commission evaluations of Rethink Medical innovation proposals.
Forbes Spain — 24 Changemakers 2024
Founder recognition
Rethink Medical founder Manuel Luque was recognised among Forbes Spain's 24 Changemakers in 2024.

EAUN Scientific Research Award 2025
First Scientific Research Prize
First Scientific Research Prize at the 2025 EAUN Congress.
Newsroom

Rethink Medical has contributed to a new study published in Revista ENFURO exploring urinary management and unmet needs among people with spinal cord injury.
Read more
Rethink Medical participated in the 48th Congress of the Spanish Neuroscience Nursing Association, sharing the journey from identifying an unmet need in clinical practice to developing a regulated medical device.
Read more
Rethink Medical reached the minimum target of its 2026 investment round ahead of the initially planned closing date.
Read moreTalk to our team about product evaluation, training programmes and availability in your market.